| 000 | 00982 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517195914.0 | ||
| 264 | 0 | _c20190118 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1527-3350 | ||
| 024 | 7 |
_a10.1002/hep.29821 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLampertico, Pietro | |
| 245 | 0 | 0 |
_aLess can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _c08 2018 |
||
| 300 |
_a397-400 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAlanine Transaminase |
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aHepatitis B e Antigens |
| 650 | 0 | 4 | _aHepatitis B virus |
| 650 | 0 | 4 | _aHepatitis B, Chronic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aBerg, Thomas | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 68 _gno. 2 _gp. 397-400 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.29821 _zAvailable from publisher's website |
| 999 |
_c28025667 _d28025667 |
||